Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole vs Risperidone on Mitochondrial Dysfunction in Schizophrenia
NCT06236451Phase 4Completed
- Sponsor
- AIIMS New Delhi
- Start
- Apr 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of aripiprazole in schizophrenia, sponsored by AIIMS New Delhi. Primary endpoint: Change in Mitochondrial respiratory chain complex I activity/concentration at 12 weeks. Started Apr 2024; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT06236451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06236451.